HighTower Advisors LLC Has $23.49 Million Stock Holdings in Agilent Technologies, Inc. $A

HighTower Advisors LLC lifted its position in Agilent Technologies, Inc. (NYSE:A) by 3.3% during the 2nd quarter, Holdings Channel reports. The firm owned 176,828 shares of the medical research company’s stock after buying an additional 5,710 shares during the quarter. HighTower Advisors LLC’s holdings in Agilent Technologies were worth $23,488,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in A. Norges Bank bought a new stake in Agilent Technologies during the fourth quarter worth about $549,158,000. AQR Capital Management LLC raised its stake in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. raised its stake in shares of Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the last quarter. Balyasny Asset Management L.P. boosted its holdings in shares of Agilent Technologies by 192.0% in the 4th quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock worth $192,204,000 after acquiring an additional 928,821 shares in the last quarter. Finally, SG Americas Securities LLC boosted its holdings in shares of Agilent Technologies by 107.2% in the 1st quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company’s stock worth $190,900,000 after acquiring an additional 866,641 shares in the last quarter.

Agilent Technologies Trading Down 0.5%

A stock opened at $148.55 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a market cap of $41.95 billion, a P/E ratio of 29.83, a PEG ratio of 2.63 and a beta of 1.25. The business has a fifty day moving average of $135.38 and a 200-day moving average of $125.56.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company earned $1.31 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. TD Cowen raised their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. HSBC decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.